Aarti Pharmalabs Ltd Share Price

₹760.40 -19.60 (-2.51%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:758.00
  • Day's High:781.80

  • 52 Week Low557.20
  • 52 Week High971.50

Aarti Pharmalabs Ltd's key Fundamentals

Market Cap ₹7,070 Cr.
P/E Ratio 28.9
TTM EPS 27
P/B Ratio 3.71
ROE 14.73
Debt to Equity 0.21
Face Value 5
BVPS 210
3 Year Sales Growth 23.47%

Aarti Pharmalabs Ltd's Share Price Returns

1 Day -2.51%
1 Week 4.00%
1 Month 11.70%
3 Months -9.80%
6 Months -11.50%
1 Years 30.30%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Aarti Pharmalabs Ltd Shareholding Pattern

Promoters

(42.88%)

Institutions

(14.99%)

Non-Institutions

(42.13%)

Pledged shares as % of Promoter's holding (%)

(0.01%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited (APL) (Formerly known as Aarti Organics Limited) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint.

Over the past two decades, enabled by cutting-edge R&D and manufacturing capabilities APL has evolved as a reliable partner of choice for generic players and innovators across the globe. The company specialises in generic APIs, generic intermediates, and xanthine derivatives. It delivers CDMO services for drug substance/NCE development and manufacturing for innovative pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products.

With the biggest manufacturing capacity in India for its flagship product ‘Caffeine’ APL has emerged as a preferred partner for the Beverages, Nutraceuticals manufacturing companies, and Pharmaceuticals Industries across the world.

Business area of the company

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).

Products and services

  • API
  • Intermediates
  • CDMO Services
  • Caffeine
  • Xanthine Derivatives
  • Acid & Allied

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 758.00
  • Day's High: 781.80

  • 52 Week Low557.20
  • 52 Week High971.50

Aarti Pharmalabs Ltd's key Fundamentals

Market Cap ₹7,070 Cr.
P/E Ratio 28.9
TTM EPS 27
P/B Ratio 3.71
ROE 14.73
Debt to Equity 0.21
Face Value 5
BVPS 210
3 Year Sales Growth 23.47%

Aarti Pharmalabs Ltd's Share Price Returns

1 Day -2.51%
1 Week 4.00%
1 Month 11.70%
3 Months -9.80%
6 Months -11.50%
1 Years 30.30%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×